United States considers drug stockpile

Woodward, Cal
November 2011
CMAJ: Canadian Medical Association Journal;11/8/2011, Vol. 183 Issue 16, pE1171
Academic Journal
The article reports on the shortage of drugs in the U.S. It mentions that the government of the country have considered the establishment of a national respiratory for cancer medications that people have a hard time getting. It also notes that proposals have played a role in influencing the U.S. Food & Drug Administration in the supply chains.


Related Articles

  • Struggling with Shortages. Wechsler, Jill // Pharmaceutical Executive;Nov2011, Vol. 31 Issue 11, p12 

    The article focuses on the drug shortage crisis in the U.S. during 2010 and 2011, which is mainly due to supply chain problems in the pharmaceutical industry. The U.S. Food & Drug Administration (FDA) recorded 178 drug shortages in the U.S. in 2010, up from 157 in 2009; and three-fourths of the...

  • FDA warns drug shortage may include bleomycin.  // Dermatology Times;Aug2000, Vol. 21 Issue 8, p5 

    Reports on the shortage of some drugs in the United States due to manufacturing problems according to the United States Food and Drug Administration. Bleomycin sulfate; Hyaluronidase; Flumazenil; Drug uses.

  • Drug shortages soar 300 percent; FDA perplexed.  // Medical Marketing & Media;May2002, Vol. 37 Issue 5, p40 

    Reports the increase in drug shortages in the U.S. Effect of Federal Drug and Administration (FDA) policy on drug shortages; Decrease in the number of facilities manufacturing sterile injectables; Limitations in the control of FDA on drug shortages.

  • Shortages Report.  // Pharmacy Today;Apr2012, Vol. 18 Issue 4, p26 

    The article reports on the steps undertaken by the U.S. Food and Drug Administration (FDA) to address shortages of two cancer medications such as importing doxorubicin hydrochloride liposome injection and prioritizing the review of APP Pharmaceutical Inc.'s methotrexate.

  • Adequan shortage imminent due to FDA-driven factory renovations.  // DVM: The Newsmagazine of Veterinary Medicine;Jul2013, Vol. 44 Issue 7, p52 

    The article reports on the imminent supply shortage of the polysulfated glycosaminoglycan drug, Adequan i.m., due to renovations at the U.S. Food and Drug Administration's (FDA) Shirley, New York-based manufacturing facility.

  • Struggling with Shortages. Wechsler, Jill // Pharmaceutical Representative;Nov2011, Vol. 41 Issue 11, p26 

    The article focuses on how to address drug shortage crisis and supply chain problems in the U.S. It says that the U.S. Food and Drug Administration (FDA) public workshop provides a forum for patient advocates, health professionals, drug distributors and manufacturers. It states that drug...

  • Safe and Secure. Kontnik, Lewis T.; Dahod, Shabbir // Pharmaceutical Executive;Sep2004, Vol. 24 Issue 9, p58 

    Reports on the effort of the U.S. Food and Drug Administration to fight counterfeiting drugs. Establishment of a task force against counterfeiting; Way of threatening the security of the drug supply chain; Development of effective technology for tracking and accounting for medicines. INSETS:...

  • FDA paves green lane. EDMONSON, R. G. // Journal of Commerce (1542-3867);2/16/2009, Vol. 10 Issue 7, p26 

    The article focuses on a proposal for the secure supply chain pilot program launched by the U.S. Food and Drug Administration (FDA) which will streamline its entry processes for imported drugs and active pharmaceutical ingredients for a limited number of qualified importers. According to Carl...

  • HDMA Lauds FDA Guidance on SNIs.  // Chain Drug Review;4/26/2010, Vol. 32 Issue 8, p224 

    The article focuses on the relevance of standardized numerical identifiers (SNI) from the Food and Drug Administration (FDA) to drug supply chains in the U.S.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics